Grond S, Hall J, Spacek A, Hoppenbrouwers M, Richarz U, Bonnet F
Klinik für Anästhesiologie, Martin-Luther-Universität Halle-Wittenberg, Halle, Germany.
Br J Anaesth. 2007 Jun;98(6):806-15. doi: 10.1093/bja/aem102.
The fentanyl iontophoretic transdermal system (fentanyl ITS) enables needle-free, patient-controlled analgesia for postoperative pain management. This study compared the efficacy, safety, and ease of care of fentanyl ITS with patient-controlled, i.v. analgesia (PCIA) with morphine for postoperative pain management.
A prospective, randomized, multicentre trial enrolled patients in Europe after abdominal or orthopaedic surgery. Patients received fentanyl ITS (n = 325; 40.0 microg fentanyl over 10 min) or morphine PCIA [n = 335; bolus doses (standard at each hospital)] for < or =72 h. Supplemental i.v. morphine was available during the first 3 h. The primary efficacy measure was the patient global assessment (PGA) of the pain control method during the first 24 h.
PGA ratings of 'good' or 'excellent' were reported by 86.2 and 87.5% of patients using fentanyl ITS or morphine PCIA, respectively (95% CI, -6.5 to 3.9%). Mean (sd) last pain intensity scores (numerical rating scale, 0-10) were 1.8 (1.77) and 1.9 (1.86) in the fentanyl ITS and morphine PCIA groups, respectively (95% CI, -0.38 to 0.18). More patients reported a system-related problem for fentanyl ITS than morphine PCIA (51.1 vs 17.9%, respectively). However, fewer of these problems interrupted pain control (4.4 vs 41.3%, respectively). Patients, nurses, and physiotherapists reported more favourable overall ease-of-care ratings for fentanyl ITS than morphine PCIA. Study termination rates and opioid-related side-effects were similar between groups.
Fentanyl ITS and morphine PCIA were comparably effective and safe.
芬太尼离子导入透皮系统(fentanyl ITS)可为术后疼痛管理提供无针、患者自控镇痛。本研究比较了芬太尼ITS与吗啡患者自控静脉镇痛(PCIA)用于术后疼痛管理的疗效、安全性及护理便捷性。
一项前瞻性、随机、多中心试验纳入了欧洲腹部或骨科手术后的患者。患者接受芬太尼ITS(n = 325;10分钟内给予40.0微克芬太尼)或吗啡PCIA [n = 335;推注剂量(各医院标准剂量)],持续≤72小时。最初3小时内可静脉补充吗啡。主要疗效指标为最初24小时内患者对疼痛控制方法的总体评估(PGA)。
使用芬太尼ITS或吗啡PCIA的患者中,分别有86.2%和87.5%报告疼痛控制为“良好”或“优秀”(95%CI,-6.5%至3.9%)。芬太尼ITS组和吗啡PCIA组的平均(标准差)末次疼痛强度评分(数字评分量表,0 - 10)分别为1.8(1.77)和1.9(1.86)(95%CI,-0.38至0.18)。报告芬太尼ITS系统相关问题的患者多于吗啡PCIA(分别为51.1%和17.9%)。然而,这些问题中干扰疼痛控制的较少(分别为4.4%和41.3%)。患者、护士和物理治疗师对芬太尼ITS的总体护理便捷性评分高于吗啡PCIA。两组的研究终止率和阿片类药物相关副作用相似。
芬太尼ITS和吗啡PCIA的疗效和安全性相当。